Pfizer Inc (NYSE:PFE)

Wednesday’s trading has closed, but PFE is being traded in the after-hours session. After-Hours quote »
34.64
Delayed Data
As of 4:01pm ET
 +0.08 / +0.23%
Today’s Change
27.51
Today|||52-Week Range
34.97
+11.20%
Year-to-Date
Merck KGaA's Q4 Net Income Flat Y/Y, Provides 2015 Outlook - Analyst Blog
11:16am / Zacks.com
Eli Lilly Extends Phase III Cholesterol Study by Six Months - Analyst Blog
Feb 20 / Zacks.com
3 Companies That Could Unlock Shareholder Value Through a Split or Spinoff
9:09am / MotleyFool.com
Five big challenges facing Sanofi's new chief Olivier Brandicourt
Feb 20 / FT.com
Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That
8:03am / MotleyFool.com
Dow 30 Stock Roundup: Wal-Mart Beats on Earnings, Coke Hikes Dividend - Analyst Blog
Feb 20 / Zacks.com
Streetinsider.com's Hot Lunchtime Reads 3/3: (AAPL) (LL) (JKS) (TXN) (BOX)
Mar 03 / Investing Channel
$20 Billion Market: Whatbs the Best Stock to Buy?
Feb 20 / MotleyFool.com
3 Stocks Moving The Drugs Industry Upward
Mar 02 / TheStreet.com
Compound sharing boosts drugs success
Feb 16 / FT.com
3 Best Performing Stocks in February - Analyst Blog
Mar 02 / Zacks.com
Pharma takes a dose of sense from the deals doctor
Feb 06 / FT.com
Stock Market News for March 02, 2015 - Market News
Mar 02 / Zacks.com
Australia's S&P/ASX 200 on way to record win streak
Feb 05 / FT.com
How and Where to Invest to Outmaneuver the Risks of Disinflation
Mar 02 / TheStreet.com
Pfizer: only in America
Feb 05 / FT.com
Dow 30 Stock Roundup: Home Depot Beats, Chevron Issues $6B in Bonds - Analyst Blog
Feb 27 / Zacks.com
Pfizer's $17bn Hospira buy could lead to break-up
Feb 05 / FT.com
Whobs Next In The Pharma Buyout Boom?
Feb 26 / Investing Channel
Q&A: Why has Pfizer bought Hospira?
Feb 05 / FT.com
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
Pfizer steps up M&A with $17bn deal to buy Hospira
Feb 05 / FT.com
5 Things Biogen Idec Inc's Management Wants You to Know
Feb 25 / MotleyFool.com
The risks and rewards of a US tax on offshore cash
Feb 04 / FT.com
Meet MannKind Corporation's New Boss (No, the Other One)
Feb 24 / MotleyFool.com
Ackman's Pershing Square secures seat on Zoetis board
Feb 04 / FT.com
Agilent-ONO Companion Diagnostics Aim - Analyst Blog
Feb 23 / Zacks.com
GlaxoSmithKline upbeat as it eyes HIV spin-off
Feb 04 / FT.com
Pfizer Rapamune Under FDA Priority Review for Lung Disease - Analyst Blog
Feb 23 / Zacks.com
Stocks: 4 things to know before the open
Feb 04 / CNNMoney.com
Did Researchers Just Discover a Cure for HIV/AIDS?
Feb 22 / MotleyFool.com
Rising dollar hits US corporate earnings
Feb 03 / FT.com
The $10 Billion Reason That This Tiny Biotech Stock Could Soar
Feb 22 / MotleyFool.com
Offshore corporate cash piles at risk from Obama tax plan
Feb 02 / CNNMoney.com
Pssst... Pfizer Just Told Investors That This is the Next Big Thing
Feb 21 / MotleyFool.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com
Could This Disruptive New Technology Lead to a Cure for Cancer?
Feb 21 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account